FDA-RFQ-134723_Amendment 0001_QA.pdf

PDF 297 KB Posted

Attached to
MS Instrument Relocation
Solicitation number
FDA-RFQ-134723
Issued by

About this file

This is an Amendment (Questions and Answers) document to Solicitation FDA-RFQ-134723 for MS Instrument Relocation to DENHAFL, issued by the U.S. Food and Drug Administration on July 29, 2026. The Contracting Officer is Sarah Hussain (sarah.hussain@fda.hhs.gov, 301-796-3940).

The solicitation requires the relocation of one Agilent 8800 ICP-MS instrument (Serial Number JP14340352) with an SPS4 Autosampler module (Model G8410A, Serial Number AU19056287) from the FDA San Francisco Human and Animal Food Laboratory (SANHAFL) in Alameda, California to the FDA Denver Human and Animal Food Laboratory (DENHAFL) in Denver, Colorado. The primary instrument system and both primary modules are operational, though an accessory chiller unit and vacuum pump have been removed. The contractor must perform disassembly, packing in newly manufactured protective shipping containers/crates, and transport with liability assumption for damage during delivery, including inside delivery to the designated location on an FOB Destination basis. All work must be performed by OEM-certified technicians. The Period of Performance extends from the Date of Contract Award through 90 calendar days after award, with delivery accepted Monday–Friday, 8:00 AM–4:00 PM local time. No expedite services are required. Reassembly, re-qualification, preventive maintenance, and IQ/OQ services are explicitly excluded from the scope. No site visit will be provided, and a detailed inventory will be provided post-award.

View the file

Other files

File Type Posted
FDA-RFQ-134723_Final.pdf PDF

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Solicitation No. FDA-RFQ-134723 —Amendment (Questions and Answers)

AMENDMENT TO SOLICITATION

Questions and Answers

Solicitation No.: FDA-RFQ-134723

Amendment No.: Amendment 0001 to RFQ

Title: MS Instrument Relocation to DENHAFL

Effective Date: 7/29/2026

Issued By:

U.S. Food and Drug Administration — Contracting Officer: Sarah Hussain, sarah.hussain@fda.hhs.gov, 301-796-3940

Purpose:

This amendment is issued to provide answers to questions submitted by prospective offerors in accordance with Section B (Offer Submission) of the solicitation. Except as provided in this amendment, all terms, conditions, and requirements of the solicitation remain unchanged.

Q# Question Received Government Response Solicitation Reference

Status

Questions Received — Submission 1

Origin lab name, address, and point of contact?

FDA San Francisco Human and Animal Food Laboratory (SANHAFL), 1201 Harbor Bay Pkwy, Alameda, CA 94502.

Sec. 2; Sec.

6.9

Answered

Destination lab name, address, and point of contact?

FDA Denver Human and Animal Food Laboratory (DENHAFL), 1 Denver Federal Center, Bldg. 20, 6th Ave & Kipling St, Entr. W10, Denver, CO 80225.

Sec. 2; Sec.

6.9

Answered

3 Billing address?

billing/remit-to address will be in the awarding PO, invoicing is handled solely via the Invoice Processing Platform (IPP) per the Electronic Invoicing clause.

see Sec. 5B, IPP clause

Answered

Please indicate consent to reach out to any necessary transport vendors, etc.

The PWS contemplates performance by OEM-certified technicians;

transport vendors is the responsibility of the contractor, the prime contractor will be solely responsible for maintaining the terms and

Sec. 5A (52.244-6)

Answered

Q# Question Received Government Response Solicitation Reference

Status conditions of the RFQ and requirements. It is not for FDA to determine, consent on how the contractor intends to provide the services requested from the prime contractor

Are the systems operational?

Primary instrument system is operational but an accessory Chiller unit and a vacuum pump that broke and have been removed. The two primary instrument modules (ICP-MS

8800 and SPS4 Autosampler), are functional.

Answered

Reason for the move/service?

The Agilent 8800 ICP-MS instrument is no longer needed at the FDA San Francisco Human and Animal Food Laboratory (SANHAFL) and must be relocated to the FDA Denver Human and Animal Food Laboratory

(DENHAFL).

Sec. 6.1 Answered

Will the project move in phases?

The solicitation scopes this as a single Lot (CLIN 0001, Qty 1) covering one instrument, with a single set of deliverables due within 90 calendar days of award — indicating a single, non-phased move. Crated system components should be delivered to destination, and this will complete the requirement.

Sec. 3; Sec.

6.6

Answered

When do you need the relocation – please note if you would like expedite charges included in the quote?

Period of Performance: Date of Contract Award through 90 calendar days after Date of Contract Award, unless the Government approves a different delivery schedule. Delivery is to be accepted Monday–Friday, 8:00 AM–4:00 PM local time.

No expedite services required.

Sec. 2; Sec.

6.10

Q# Question Received Government Response Solicitation Reference

Status

Please provide info for all systems that need to move (if you have >2 systems please provide a spreadsheet):

One (1) system is within scope: Agilent 8800 ICP-MS instrument, S/N JP14340352, and SPS4 Autosampler module (Model G8410A, S/N AU19056287). Detailed list to be provided after award.

Sec. 3; Sec.

6.1; Sec. 6.4

Answered

Will there be PCs/Monitors/Printers involved in the move (please provide specs if so)?

Please reference the RFQ which states that the Agilent 8800 ICP-MS instrument and all associated modules and accessories" —no PCs/Monitors/Printers are identified for the move.

Sec. 6.3; Sec.

6.4

Answered

Services requested — Deinstall/Disassembly (Y/N)?

Y — the Contractor shall provide any necessary disassembly and packing of the instrument, as needed, performed by an OEM-certified service technician. The contractor shall ensure that any necessary disassembly includes draining the system of any solvents/liquids prior to crating/ shipment.

Sec. 6.4 Answered, Services requested — Packaging (Y/N)?

Y — the instrument is to be packed into appropriate protective shipping containers/crates by an OEM-certified technician; all packing materials/crates must be newly manufactured and become FDA property upon delivery.

Sec. 6.4; Sec.

6.5; Sec. 6.6

Answered

If moving within the same building, do you have a cart available?

(Y/N)?

Not applicable — this is not an intra-building move. The move is interstate, from SANHAFL in Alameda, CA to DENHAFL in Denver, CO.

Sec. 2; Sec.

6.9

Answered

Packaging Service (Y/N)?

Y—see answer to question 12 Answered

Services requested — Transport (Y/N)?

Y — the Contractor shall transport the crated system and all components to DENHAFL and assume liability for damage during transportation/delivery, including inside delivery to the location

Sec. 2; Sec.

6.4; Sec. 6.8

Q# Question Received Government Response Solicitation Reference

Status designated by the lab POC. FOB Destination.

Services requested — Reinstall (Y/N)?

N — reassembly is explicitly outside the scope of this requirement. The PWS states the system must remain capable of being reassembled and re-qualified at a later date by OEM-certified service technicians, and that reassembly/re-qualification are outside the scope of this requirement.

Sec. 6.4 Answered

Services requested — Post-move Preventive Maintenance (PM) (Y/N)?

N (inferred) — not identified as a deliverable; consistent with reassembly/re-qualification being excluded from scope.

Sec. 6.4; Sec.

6.6

Answered

Services requested — Post-move IQ/OQ, GMP-qualified labs only (Y/N)?

N (inferred) — re-qualification is explicitly identified as outside the scope of this requirement.

Sec. 6.4 Answered

Questions Received — Submission 2

Is there going to be a site visit for this RFQ?

No Answered

Will you provide an inventory for this RFQ?

One (1) system is within scope: Agilent 8800 ICP-MS instrument, S/N JP14340352, and SPS4 Autosampler module (Model G8410A, S/N AU19056287). Detailed list to be provided after award.

Sec. 3; Sec.

6.1; Sec. 6.4

Answered

Except as amended herein, all terms and conditions of solicitation FDA-RFQ-134723 remain unchanged and in full force and effect.

File details come from the government source that posted it. Updated .